Becton, Dickinson and Company (BDX) Financials
BDX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 52.3 billion | 26.9 billion |
2023-09-30 | 52.8 billion | 27.0 billion |
2023-06-30 | 53.0 billion | 27.1 billion |
2023-03-31 | 54.4 billion | 28.7 billion |
BDX Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 725.0 million | 83.0 million |
2023-09-30 | 1.0 billion | 58.0 million |
2023-06-30 | 889.0 million | 56.0 million |
2023-03-31 | 3.0 million | 56.0 million |
BDX Net Income
Date | Net Income |
---|---|
2023-12-31 | 281.0 million |
2023-09-30 | 154.0 million |
2023-06-30 | 407.0 million |
2023-03-31 | 460.0 million |
BDX Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.2 billion | - | - |
2023-09-30 | 1.4 billion | 14.7 billion | - |
2023-06-30 | 931.0 million | 14.9 billion | - |
2023-03-31 | 2.0 billion | 16.0 billion | - |
BDX Shares Outstanding
BDX Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 116.0 million | 290.0 million | 1.2 billion | - |
2023-09-30 | 294.0 million | 281.0 million | 1.1 billion | - |
2023-06-30 | 191.0 million | 306.0 million | 1.2 billion | - |
2023-03-31 | 181.0 million | 337.0 million | 1.2 billion | - |
BDX Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.7 billion | 2.7 billion |
2023-09-30 | 5.1 billion | 3.4 billion |
2023-06-30 | 4.9 billion | 2.8 billion |
2023-03-31 | 4.8 billion | 2.6 billion |
BDX
List: Champions
Price: 246.53USD
Dividend Yield: 1.57%
Forward Dividend Yield: 1.54%
Payout Ratio: 87.16%
Dividend Per Share: 3.80 USD
Earnings Per Share: 4.36 USD
P/E Ratio: 54.71
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 2.1 million
Ebitda: 554.0 millionMarket Capitalization: 69.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 4.29%
DGR5: 3.60%
DGR10: 5.77%
DGR20: 10.12%